Sequoia invests in Chinese AI drug startup

AI and pharmaceuticals are two of the hottest sectors in China right now. Sequoia's investment in DIP covers both of them.

Sequoia invests in Chinese AI drug startup

Sequoia Capital China completed almost $15 million Series B investment in Beijing-based Deep Intelligent Pharma DIP, a Chinese startup that provides artificial intelligence AI technology for drug development, on September 28, though it was not announced until October 9.

DIP develops AI technologies throughout the whole drug RD process and most recently released an AI system that monitors adverse reactions to drugs a fresh application for AI use in the medical...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Print Edition

FinanceAsia Print Edition